| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Green WR et al. | Asperillosis of the orbit. Report of ten cases and review of the literature. | 1969 | Arch. Ophthalmol. | pmid:5806054 |
| Bell RW and Ritchey JP | Subconjunctival nodules after amphotericin B injection. Medical therapy for Aspergillus corneal ulcer. | 1973 | Arch. Ophthalmol. | pmid:4126867 |
| Scheibler E et al. | Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans. | 2018 | Arch. Oral Biol. | pmid:29477025 |
| Curvelo JA et al. | Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? | 2014 | Arch. Oral Biol. | pmid:24907522 |
| Peixoto LR et al. | Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp. | 2017 | Arch. Oral Biol. | pmid:27771586 |
| Nikawa H et al. | The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin. | 1994 | Arch. Oral Biol. | pmid:7741664 |
| Ellepola AN and Samaranayake LP | Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. | 1998 | Arch. Oral Biol. | pmid:9877331 |
| Dorocka-Bobkowska B et al. | Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro. | 2003 | Arch. Oral Biol. | pmid:14596870 |
| El-Hawash SA et al. | Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities. | 2006 | Arch. Pharm. (Weinheim) | pmid:17009301 |
| Mete E et al. | Synthesis and antifungal activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols. | 2010 | Arch. Pharm. (Weinheim) | pmid:20232370 |
| Ruzicková J and Parrák V | [Determination of the sterility of nystatin and Natamycin by UV spectrophotometry (author's transl)]. | 1982 | Arch. Pharm. (Weinheim) | pmid:6981393 |
| Elmegeed GA et al. | Synthesis and antimicrobial evaluation of some novel cholestane heterocyclic derivatives. | 2004 | Arch. Pharm. (Weinheim) | pmid:15038058 |
| Sakeer K et al. | Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. | 2010 | Arch. Pharm. Res. | pmid:21116780 |
| Weissmann G et al. | Arthritis induced by filipin in rabbits. | 1967 | Arthritis Rheum. | pmid:4227672 |
| Polatti F et al. | Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections. | 2003 | Arzneimittelforschung | pmid:14650366 |
| Goldstein DJ et al. | Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment. | 1995 Oct-Dec | ASAIO J. | pmid:8589469 |
| Pérez Prim FJ and Vila I | [Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis]. | 2002 | Aten Primaria | pmid:12525346 |
| Bastiaan RJ | Denture sore mouth. Aetiological aspects and treatment. | 1976 | Aust Dent J | pmid:797370 |
| Quirk PC et al. | Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation. | 1995 | Aust Dent J | pmid:7575286 |
| Dennerstein GJ and Langley R | Vulvovaginal candidiasis: treatment and recurrence. | 1982 | Aust N Z J Obstet Gynaecol | pmid:6963163 |